Compounds > cyclopentane
Page last updated: 2024-08-21

cyclopentane and Drug Withdrawal Symptoms

cyclopentane has been researched along with Drug Withdrawal Symptoms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Novák, K; Pałucha-Poniewiera, A; Pilc, A1
Bespalov, AY; Danysz, W; Sukhotina, IA; Zvartau, EE1
Biala, G; Bochenski, M; Danysz, W; Kotlinska, J; Rafalski, P1
Danysz, W; Hölter, SM; Spanagel, R1
Bespalov, AY; Sukhotina, IA1
Headley, MP; Houghton, AK; Parsons, CG1

Other Studies

6 other study(ies) available for cyclopentane and Drug Withdrawal Symptoms

ArticleYear
Group III mGlu receptor agonist, ACPT-I, attenuates morphine-withdrawal symptoms after peripheral administration in mice.
    Progress in neuro-psychopharmacology & biological psychiatry, 2009, Nov-13, Volume: 33, Issue:8

    Topics: Analysis of Variance; Animals; Body Weight; Cyclopentanes; Disease Models, Animal; Dose-Response Relationship, Drug; Head Movements; Male; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Receptors, Metabotropic Glutamate; Substance Withdrawal Syndrome; Time Factors; Tremor; Tricarboxylic Acids

2009
Caffeine withdrawal syndrome in social interaction test in mice: effects of the NMDA receptor channel blockers, memantine and neramexane.
    Behavioural pharmacology, 2004, Volume: 15, Issue:3

    Topics: Animals; Caffeine; Cyclopentanes; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Memantine; Mice; Motor Activity; Receptors, N-Methyl-D-Aspartate; Social Behavior; Substance Withdrawal Syndrome; Time Factors

2004
Effect of neramexane on ethanol dependence and reinforcement.
    European journal of pharmacology, 2004, Oct-25, Volume: 503, Issue:1-3

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Behavior, Animal; Central Nervous System Depressants; Conditioning, Operant; Cyclopentanes; Ethanol; Male; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reinforcement, Psychology; Seizures; Substance Withdrawal Syndrome; Taurine

2004
Novel uncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 292, Issue:2

    Topics: Alcohol Drinking; Animals; Cyclopentanes; Discrimination Learning; Dose-Response Relationship, Drug; Drinking; Male; Neuroprotective Agents; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Self Administration; Substance Withdrawal Syndrome; Time Factors

2000
Effects of the NMDA receptor channel blockers memantine and MRZ 2/579 on morphine withdrawal-facilitated aggression in mice.
    Psychopharmacology, 2000, Volume: 149, Issue:4

    Topics: Aggression; Animals; Cyclopentanes; Excitatory Amino Acid Antagonists; Male; Memantine; Mice; Morphine; Narcotics; Receptors, N-Methyl-D-Aspartate; Social Behavior; Substance Withdrawal Syndrome

2000
Mrz 2/579, a fast kinetic NMDA channel blocker, reduces the development of morphine tolerance in awake rats.
    Pain, 2001, Volume: 91, Issue:3

    Topics: Analgesics, Opioid; Animals; Cyclopentanes; Drug Tolerance; Male; Morphine; Neuroprotective Agents; Pain; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Sodium Chloride; Substance Withdrawal Syndrome; Wakefulness

2001